Navigation Links
OTC sale for Xenical; Diet Drug; gets FDA approval

Prescription diet drug Xenical manufactured by GlaxoSmithkline got a nod for OTC sale from FDA.It received an "approvable" letter from the Food// and Drug Administration so that it can be marketed once the company addresses additional questions from regulators. An estimated arrival time for the sale is early next year.

It would become the first F.D.A.-approved weight-loss product sold without a doctor's prescription. The diet drug has been christened Alli.

A federal advisory panel voted 11 to 3 in January that the drug, which works by blocking fat absorption, could be sold without a prescription.

Although Xenical has been available as a prescription drug since 1999, it never got the star status partly because about half of the people who use it have episodes of diarrhoea, oily stools and flatulence because of fat that is excreted from the body rather than absorbed.

Clinical studies of the lower-dose over-the-counter version have shown that people using the drug lose more than their counterparts on similar diets who do not take the medication — an average of about five to six additional pounds more over six months. About 18 percent lose 10 percent or more of their initial body weight.

If it wins final approval, it would be the only FDA-endorsed weight-loss drug available without a prescription. But some experts express concern about people regaining weight after they stop using the drug, as well as whether people will be able to tell if it is safe for them without a doctor's advice. The drug can also lead to hepatitis, gallstones and kidney stones, although the exact cause is not clear.

But Gbola Amusa, an analyst in London for Sanford C. Bernstein & Company, said, "I'm assuming that the F.D.A. is addressing some things related to how they can ensure that this drug is not used inappropriately”.

So the diet pill Xenical would soon be seen in shops.


'"/>




Page: 1

Related medicine news :

1. Ranbaxy gets US FDA approval for Lisinopril
2. Aurobindo gets U.S. FDA approval for Cephalexin
3. Cadila gets US FDA approval for Promethazine tablets
4. Anti-obesity drugs for FDA approval
5. Grand FDA nod and approval for drug for heart transplant patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology: